Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1AFAMELANOTIDE[1] Afamelanotide[2] Afamelanotide ,
Afamelanotide acetate 💬
[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[2] 159, 254 💬
2Afamelanotide (16 mg implant)[1] Afamelanotide[2] Afamelanotide ,
Afamelanotide acetate 💬
[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[1] 159 💬
3Biospecimen Collection----[18] 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
4Ipilimumab[1] Ipilimumab[1] Ipilimumab 💬 [1] CTLA4 💬 [4] Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Rheumatoid arthritis, T cell receptor signaling pathway 💬[9] 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
5Isotretinoin[1] Isotretinoin[1] Isotretinoin 💬 [2] RARA,
RARB 💬
[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[4] 36, 39, 159, 160 💬
6Liposomal T4N5 lotion----[1] 159 💬
7Melatonin[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[18] 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
8Nivolumab[1] Nivolumab[1] Nivolumab 💬 [1] PDCD1 💬 [3] Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
9SCENESSE----[3] 159, 161, 254 💬
10TRABECTEDINA----[1] 159 💬
11Trabectedine----[1] 159 💬
12YONDELIS 0,25 mg polvo para concentrado para solución para perfusión----[1] 159 💬
13Yondelis 0.25 mg powder for concentrate for solution for infusion.----[1] 159 💬
14YONDELIS 1 mg polvo para concentrado para solución para perfusión----[1] 159 💬
15Yondelis 1 mg powder for concentrate for solution for infusion.----[1] 159 💬